Tony Michael Argenbright

Array ( [id] => 7651807 [patent_doc_number] => 20110301076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'ANTIMICROBIAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/122156 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12415 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301076.pdf [firstpage_image] =>[orig_patent_app_number] => 13122156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495104 [patent_doc_number] => 20100286048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Albumin Fusion Proteins' [patent_app_type] => utility [patent_app_number] => 12/570397 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 139704 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286048.pdf [firstpage_image] =>[orig_patent_app_number] => 12570397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6423974 [patent_doc_number] => 20100168032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Smart Pro-Drugs of Serine Protease Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/568210 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 108 [patent_figures_cnt] => 108 [patent_no_of_words] => 26442 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168032.pdf [firstpage_image] =>[orig_patent_app_number] => 12568210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9537238 [patent_doc_number] => 20140161886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'MINERAL-COATED MICROSPHERES' [patent_app_type] => utility [patent_app_number] => 13/879178 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13648 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9937498 [patent_doc_number] => 08987306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-24 [patent_title] => 'Inhibitors of integrin alpha2beta1 based on prolyl diaminopropionic acid scaffold' [patent_app_type] => utility [patent_app_number] => 12/566162 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 15818 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12566162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490154 [patent_doc_number] => 20110237522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'NEUTRAL NANOTRANSPORTERS' [patent_app_type] => utility [patent_app_number] => 13/120341 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 32120 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237522.pdf [firstpage_image] =>[orig_patent_app_number] => 13120341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6356633 [patent_doc_number] => 20100087004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'PEPTIDE-PRESENTING SURFACES FOR LONG-TERM CULTURE OF PLURIPOTENT CELLS' [patent_app_type] => utility [patent_app_number] => 12/563009 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9507 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087004.pdf [firstpage_image] =>[orig_patent_app_number] => 12563009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670071 [patent_doc_number] => 20110319340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'METHODS FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 13/119926 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14122 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13119926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6486794 [patent_doc_number] => 20100093086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Stapled Peptides and Method of Synthesis' [patent_app_type] => utility [patent_app_number] => 12/561107 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12443 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093086.pdf [firstpage_image] =>[orig_patent_app_number] => 12561107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587295 [patent_doc_number] => 20110281805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'USE OF AN ANG-(1-7) RECEPTOR AGONIST IN ACUTE LUNG INJURY' [patent_app_type] => utility [patent_app_number] => 13/063685 [patent_app_country] => US [patent_app_date] => 2009-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4399 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281805.pdf [firstpage_image] =>[orig_patent_app_number] => 13063685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6025750 [patent_doc_number] => 20110053829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'DISULFIDE-LINKED POLYETHYLENEGLYCOL/PEPTIDE CONJUGATES FOR THE TRANSFECTION OF NUCLEIC ACIDS' [patent_app_type] => utility [patent_app_number] => 12/553559 [patent_app_country] => US [patent_app_date] => 2009-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 59564 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053829.pdf [firstpage_image] =>[orig_patent_app_number] => 12553559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6112935 [patent_doc_number] => 20110190199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Combination Therapy for Tuberculosis' [patent_app_type] => utility [patent_app_number] => 13/061233 [patent_app_country] => US [patent_app_date] => 2009-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18522 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190199.pdf [firstpage_image] =>[orig_patent_app_number] => 13061233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374699 [patent_doc_number] => 20090312260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'DRUG THERAPY FOR CELIAC SPRUE' [patent_app_type] => utility [patent_app_number] => 12/535587 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11828 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312260.pdf [firstpage_image] =>[orig_patent_app_number] => 12535587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374711 [patent_doc_number] => 20090312272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Transglutaminase inhibitors and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/462554 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16766 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312272.pdf [firstpage_image] =>[orig_patent_app_number] => 12462554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6253678 [patent_doc_number] => 20100028719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Surface-Immobilized Antimicrobial Peptoids' [patent_app_type] => utility [patent_app_number] => 12/533876 [patent_app_country] => US [patent_app_date] => 2009-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13953 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028719.pdf [firstpage_image] =>[orig_patent_app_number] => 12533876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374698 [patent_doc_number] => 20090312259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'LONG LASTING GLUCAGON-LIKE PEPTIDE 2 (GLP-2) FOR THE TREATMENT OF GASTROINTESTINAL DISEASES AND DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/505506 [patent_app_country] => US [patent_app_date] => 2009-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14299 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312259.pdf [firstpage_image] =>[orig_patent_app_number] => 12505506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959760 [patent_doc_number] => 20110184147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'ENZYME SUBSTRATE FOR LABELING OF PROTEIN' [patent_app_type] => utility [patent_app_number] => 13/001929 [patent_app_country] => US [patent_app_date] => 2009-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17014 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20110184147.pdf [firstpage_image] =>[orig_patent_app_number] => 13001929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784661 [patent_doc_number] => 20120046217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'TNF-alpha Antagonists Containing IGFBP5' [patent_app_type] => utility [patent_app_number] => 13/142700 [patent_app_country] => US [patent_app_date] => 2009-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7555 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046217.pdf [firstpage_image] =>[orig_patent_app_number] => 13142700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496319 [patent_doc_number] => 20090264347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Use of Blood Coagulation Factor XIII for Treating Hemophilia A' [patent_app_type] => utility [patent_app_number] => 12/495313 [patent_app_country] => US [patent_app_date] => 2009-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2410 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264347.pdf [firstpage_image] =>[orig_patent_app_number] => 12495313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458873 [patent_doc_number] => 20090259025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Lactoferrin' [patent_app_type] => utility [patent_app_number] => 12/493919 [patent_app_country] => US [patent_app_date] => 2009-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4743 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20090259025.pdf [firstpage_image] =>[orig_patent_app_number] => 12493919 [rel_patent_id] =>[rel_patent_doc_number] =>)